Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Catalyst Pharm Inc (NQ: CPRX)
3.800 USD  +0.050 (+1.33%)
Streaming Delayed Price  /  Updated: 4:11 PM EDT, Jun 20, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,515,707
Open 3.800
Bid (Size) 3.780 (2)
Ask (Size) 3.860 (10)
Prev. Close 3.750
Today's Range 3.760 - 3.970
52wk Range 1.850 - 6.160
Shares Outstanding 102,596,164
Dividend Yield N/A
Performance
YTD
+80.09%
+80.09%
1 Month
+0.26%
+0.26%
3 Month
-5.47%
-5.47%
6 Month
+69.64%
+69.64%
1 Year
+11.76%
+11.76%
Top News
More News
Catalyst Pharmaceuticals Files Federal Lawsuit Against U.S. Food and Drug Administration
Complaint Cites Multiple Violations of Food, Drug, and Cosmetic Act Read More
from GlobeNewswire News Releases
Catalyst Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference
Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic... Read More
from GlobeNewswire News Releases
More News
Read More
Catalyst Pharmaceuticals Announces Expansion of Firdapse License to Include Japan
from GlobeNewswire News Releases
Biotech Stocks: Latest Technological Developments Pushing U.S. Medical Device Market to New Levels
from PR Newswire
Biotech Stocks: Latest Technological Developments Pushing U.S. Medical Device Market to New Levels
category Featured News
from FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Catalyst Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update
from GlobeNewswire News Releases
Catalyst Pharmaceuticals Stock Prediction
category USAToday / Syndication , Frankly / Money , FinancialContent / General , and 1 more.
from Syndication Cloud
UPDATE 2-Catalyst Pharma sues FDA over approval of cheaper rival drug
category companyNews
from Reuters: Company News
UPDATE 1-Catalyst Pharma files lawsuit against FDA approval of Jacobus Pharma's drug
category companyNews
from Reuters: Company News
Catalyst Pharma files lawsuit against U.S. FDA on Jacobus Pharma drug approval
category companyNews
from Reuters: Company News
Peek Under The Hood: IEIH Has 23% Upside
category ETFs
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.